Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CT Providers

Dr. Silvio Edward Inzucchi, MD

Accepting New Patients

(No ratings)

Specializes in: Adult Endocrinology

Harvard Medical School (1985)

Professional interests include: high cholesterol (hyperlipidemia), insulin resistance, acromegaly, and more.

35 Park Street
New Haven, CT 06519

(203) 200-3636

Dr. Silvio Edward Inzucchi, MD is an endocrinologist in New Haven, CT specializing in adult endocrinology. He graduated from Harvard Medical School in 1985 and has 40 years of experience. Dr. Silvio Edward Inzucchi, MD is affiliated with Yale University, Yale New Haven Health and Smilow Cancer Hospital, Yale Medicine.

Office Locations

Address:

35 Park Street
New Haven, CT 06519

Address:

789 Howard Avenue Dana Building - 2nd Floor
New Haven, CT 06519

Some issues Dr. Silvio Edward Inzucchi, MD can help you with:

Thyroid Problems

Thyroid problems are a group of conditions that alter hormone regulation and metabolism. The thyroid is a small, butterfly-shaped gland located in the lower neck, just below the Adam's apple (laryngeal prominence) and larynx (voice box). Despite its small size, the thyroid has an outsized effect on the body by regulating hormones that control metabolism. Metabolism is the body's process of converting consumed food into fuel to power the entire body. Heart rate, weight, cholesterol, body temperature, and even physical growth and development are all affected by the metabolism.

When the thyroid malfunctions, the body is unable to properly process and allocate energy. Thyroid problems, such as hyperthyroidism (overactive thyroid) and hypothyroidism (underactive thyroid), cause irregular metabolism. In some cases, the body produces antibodies that attack the thyroid cells for unknown reasons. The damaged thyroid responds by releasing either too little or too much T3 and T4 thyroid hormones. Thyroid malfunctions may also arise from genetic causes or iodine deficiency. Thyroid problems may include:

Hashimoto's thyroiditis, an autoimmune disease that causes hypothyroidism
Graves' disease, an autoimmune disease that causes hyperthyroidism
Goiter
Thyroid nodule
Thyroid cancer

Hashimoto's is the leading cause of hypothyroidism, which is when the thyroid does not produce enough hormones to stimulate adequate metabolism. The condition is diagnosed by blood tests that measure TSH (thyroid stimulating hormone) and detect Hashimoto's antibodies. Symptoms of hypothyroidism include sluggish metabolism, inflammation, fatigue, weight gain, brittle hair, dry skin, and sensitivity to cold. To supplement impaired thyroid function, patients with Hashimoto's are typically prescribed synthetic thyroid hormone pills. Such patients may need to consume synthetic thyroids for the rest of their lives. Other treatments may include dietary changes, such as the avoidance of certain foods and medication to reduce inflammation. Frequent blood tests can inform patients if their TSH levels are within a normal range.

Grave's disease is most frequently the cause of hyperthyroidism, which is when the thyroid produces too many hormones, overstimulating one's metabolism. The condition is also diagnosed by blood tests that measure TSH and detect Grave's antibodies. Elevated heart rate, high blood pressure, sweating, bulging eyes, and weight loss are common symptoms of hyperthyroidism. Treatments for hyperthyroidism include oral radioactive iodine, which slowly shrinks the thyroid, slowing the production of excess thyroid hormone. Other anti-thyroid medications such as methimazole (Tapazole) also reduce the production of thyroid hormones. Blood pressure medications known as beta blockers can ease the increased heart rate caused by hyperthyroidism. If treatments are unsuccessful, patients may be prescribed a thyroidectomy, or surgery to remove part or all of the thyroid. Some patients with hyperthyroidism may require ophthalmological (eye medicine) treatments such as eye drops, prednisone, and surgery to reduce eye swelling and bulging.

Untreated thyroid disorders frequently lead to goiters or thyroid nodules. A thyroid goiter is a large lump that can be felt near the base of the neck and is made of swollen thyroid tissue or nodules (excess cell growth). Nodules and goiters are diagnosed by CT scan or ultrasound. Obstructive goiters can cause pain, coughing, and abnormal breathing. The most common cause of goiters is hyperthyroidism (overactive thyroid). However, Hashimoto's is also known to cause goiters or nodules. Goiters develop from continued damage from antibodies to the thyroid over time. At times, a goiter can result from a cancerous thyroid tumor. Most goiters and nodules are themselves benign.

The exact causes of thyroid cancer are unknown. People who develop thyroid cancer may or may not have another thyroid problem such as Hashimoto's or Grave's disease. Symptoms of thyroid cancer include a nodule that can be felt on the neck, hoarseness, difficulty swallowing, swelling in the neck, and neck and throat pain. CT and MRI scans are used to diagnose thyroid cancer. There are four types of thyroid cancer which vary in intensity. Thyroidectomy (thyroid removal surgery) is usually prescribed to treat thyroid cancer.

Thyroid problems are often long-term conditions that require some form of treatment. With regular monitoring and medication, many people with thyroid problems are able to lead active and fulfilling lives.

In The News (see more mentions in the news)

“According to his colleague, professor of medicine and clinical director of the endocrinology section Silvio Inzucchi, Shulman is one of the world's leading diabetes researchers.”—"Three profs elected to the American Academy of Arts and Sciences", Yale News, April 2018

“* Silvio Inzucchi, MD, Endocrinology, Diabetes, Metabolism.”—"New York Magazine: 74 New Haven physicians among best in NY metro area", New Haven Register, July 2017

“But the "number-to-treat" figure puts the drug's effectiveness close to that of cholesterol-lowering statins and possibly ahead of blood pressure medications known as ACE inhibitors, said Dr....”—"'Amazing' diabetes drug drives down fatal heart attacks and strokes, study finds", Los Angeles Times, September 2015

doctor visit	302
hospital care	147
inpatient care	147

**Gender**
Male	127
Female	167

**Ethnicity**
Non-Hispanic White	219
Black	50
Hispanic	13
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	110
From 75 to 84	74
85 and over	14
Less than 65	96

Hypertension	64
High Cholesterol	53
Stroke	5
Ischemic Heart Disease	35
Depression	22
Chronic Kidney Disease	28
Asthma	12
Osteoperosis	8
Atrial Fibrilation	13
Heart Failure	23
Chronic Obstructive Pulmonary Disease	13
Diabetes	52
Dementia	9
Cancer	11

doctor visit	337
hospital care	130
inpatient care	130

**Gender**
Male	130
Female	176

**Ethnicity**
Non-Hispanic White	224
Black	50
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	123
From 75 to 84	68
85 and over	22
Less than 65	93

Hypertension	70
High Cholesterol	58
Stroke	9
Ischemic Heart Disease	33
Depression	25
Chronic Kidney Disease	33
Asthma	14
Osteoperosis	11
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	15
Diabetes	54
Dementia	10
Cancer	13

doctor visit	350
hospital care	29
inpatient care	29

**Gender**
Male	256
Female	310

**Ethnicity**
Non-Hispanic White	422
Black	86
Hispanic	24
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	248
From 75 to 84	124
85 and over	40
Less than 65	154

Hypertension	67
High Cholesterol	56
Stroke	4
Ischemic Heart Disease	35
Depression	27
Chronic Kidney Disease	34
Asthma	17
Osteoperosis	11
Atrial Fibrilation	9
Heart Failure	20
Chronic Obstructive Pulmonary Disease	17
Diabetes	54
Dementia	8
Cancer	11

doctor visit	367
hospital care	125
inpatient care	125

**Gender**
Male	153
Female	197

**Ethnicity**
Non-Hispanic White	263
Black	47
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	157
From 75 to 84	83
85 and over	27
Less than 65	83

Hypertension	73
High Cholesterol	64
Stroke	7
Ischemic Heart Disease	43
Depression	29
Chronic Kidney Disease	47
Asthma	25
Osteoperosis	15
Atrial Fibrilation	11
Heart Failure	24
Chronic Obstructive Pulmonary Disease	21
Diabetes	54
Dementia	11
Cancer	11

doctor visit	372
hospital care	161
inpatient care	161

**Gender**
Male	158
Female	202

**Ethnicity**
Non-Hispanic White	272
Black	49
Hispanic	0
Asian	0
Other	17
Native American	0

**Age**
From 65 to 74	160
From 75 to 84	81
85 and over	32
Less than 65	87

Hypertension	75
High Cholesterol	54
Stroke	5
Ischemic Heart Disease	37
Depression	31
Chronic Kidney Disease	53
Asthma	11
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	28
Chronic Obstructive Pulmonary Disease	19
Diabetes	56
Dementia	14
Cancer	9

doctor visit	344
hospital care	107
inpatient care	107

**Gender**
Male	156
Female	166

**Ethnicity**
Non-Hispanic White	238
Black	49
Hispanic	15
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	138
From 75 to 84	84
85 and over	23
Less than 65	77

Hypertension	73
High Cholesterol	65
Stroke	7
Ischemic Heart Disease	35
Depression	31
Chronic Kidney Disease	50
Asthma	12
Osteoperosis	8
Atrial Fibrilation	12
Heart Failure	25
Chronic Obstructive Pulmonary Disease	16
Diabetes	54
Dementia	16
Cancer	12

doctor visit	267
hospital care	72
inpatient care	72

**Gender**
Male	131
Female	135

**Ethnicity**
Non-Hispanic White	194
Black	42
Hispanic	13
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	109
From 75 to 84	65
85 and over	23
Less than 65	69

Hypertension	73
High Cholesterol	62
Stroke	6
Ischemic Heart Disease	38
Depression	36
Chronic Kidney Disease	47
Asthma	12
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	23
Chronic Obstructive Pulmonary Disease	17
Diabetes	48
Dementia	18
Cancer	13

doctor visit	201
hospital care	132
inpatient care	132

**Gender**
Male	137
Female	146

**Ethnicity**
Non-Hispanic White	200
Black	43
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	119
From 75 to 84	68
85 and over	18
Less than 65	78

Hypertension	67
High Cholesterol	58
Stroke	9
Ischemic Heart Disease	37
Depression	31
Chronic Kidney Disease	49
Asthma	7
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	23
Chronic Obstructive Pulmonary Disease	12
Diabetes	50
Dementia	17
Cancer	12

doctor visit	430
hospital care	207
inpatient care	207

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Silvio Edward Inzucchi, MD for Medicare patients.

The highest averages for the top procedures that Dr. Silvio Edward Inzucchi, MD treated as an endocrinologist in New Haven, CT were hospital care and inpatient care.

doctor visit	330
hospital care	123
inpatient care	123

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Silvio Edward Inzucchi, MD.

**Gender**
Male	124
Female	149

**Ethnicity**
Black / African American	41
Asian / Pacific Islander	0
Non-Hispanic White	203
Native American / Alaskan Native	0
Hispanic	11
Other	1

**Age**
85 and over	19
75 to 84	64
Less than 65	73
65 to 74	116

Average of Total of Conditions of Medicare patients treated by Dr. Silvio Edward Inzucchi, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Silvio Edward Inzucchi, MD treated were hypertension, high cholesterol, diabetes and chronic kidney disease.

Hypertension	56
High Cholesterol	47
Stroke	5
Ischemic Heart Disease	29
Depression	23
Chronic Kidney Disease	34
Asthma	11
Osteoporosis	8
Heart Failure	18
Chronic Obstructive Pulmonary Disease	13
Diabetes	42
Atrial Fibrillation	9
Dementia	10
Cancer	9

Education & Training

Dr. Silvio Edward Inzucchi, MD graduated from Harvard Medical School in 1985. He completed residency at Yale-New Haven Hospital. He has a state license in Connecticut.

Medical School: Harvard Medical School (1985)

Residency: Yale-New Haven Hospital

Licensed In: Connecticut

Affiliations & Hospitals

Dr. Silvio Edward Inzucchi, MD is associated with these hospitals and organizations:

Yale University

Yale New Haven Health

Smilow Cancer Hospital, Yale Medicine

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Silvio Edward Inzucchi, MD appears to accept the following insurance providers: CorVel, Great-West Healthcare, WellCare, MultiPlan, Community Care Network (CCN), United Healthcare, Aetna, TRICARE, Oxford Health Plans, Medicare, Consumer Health Network, Medicaid, Humana, Cigna, Anthem, ConnectiCare, Focus Health Solutions, Prime Health, First Health, Private Healthcare Systems (PHCS), COMPWORKS, HEALTHCARE VALUE MANAGEMENT, MANAGED COMP, HUSKY and PREFERRED HEALTH WORKS.

Insurance Accepted by Provider includes:

According to our sources, Dr. Silvio Edward Inzucchi, MD accepts the following insurance providers:

CorVel

Great-West Healthcare

WellCare

MultiPlan

Community Care Network (CCN)

United Healthcare

Aetna

TRICARE

Oxford Health Plans

Medicare

Consumer Health Network

Medicaid

Humana

Cigna

Anthem

ConnectiCare

Focus Health Solutions

Prime Health

First Health

Private Healthcare Systems (PHCS)

COMPWORKS

HEALTHCARE VALUE MANAGEMENT

MANAGED COMP

HUSKY

PREFERRED HEALTH WORKS

Show More

Ratings & Reviews

Dr. Silvio Edward Inzucchi, MD does not have any reviews yet, be the first to leave a review of Dr. Silvio Edward Inzucchi, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Silvio Edward Inzucchi, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Boehringer Ingelheim International GmbH	$148,029 JARDIANCE $74,683	Empagliflozin $6,157	$67,189
Novo Nordisk AS	$92,812 Tresiba $2,040	Ozempic $1,500	$89,272
AstraZeneca AB	$89,135 FARXIGA $86,450	$2,685
Boehringer Ingelheim Pharmaceuticals, Inc.	$56,804 JARDIANCE $4,602	TRADJENTA $498	$51,703
AstraZeneca UK Limited	$50,661 FARXIGA $31,524	$19,137
Other	$302,848 JARDIANCE $45,072	Empagliflozin $30,497	SOTAGLIFLOZIN $19,312	INVOKANA $15,836	FARXIGA $15,611	Other $176,520

**Types of Payments**
Consulting Fee	$354,185
Travel and Lodging	$177,644
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$173,822
Honoraria	$26,115
Food and Beverage	$8,039
Other	$485

Research Payments

Dr. Silvio Edward Inzucchi, MD has received 1 research payments totaling $825.

Biography

Dr. Silvio Inzucchi's area of specialization is adult endocrinology. He speaks Italian. His areas of expertise include diabetes, cushing's syndrome, and growth problems. Dr. Inzucchi is professionally affiliated with Yale New Haven Health. Before performing his residency at Yale-New Haven Hospital, Dr. Inzucchi attended Harvard Medical School. Anthem, ConnectiCare, and Blue California seem to be the insurance carriers that Dr. Inzucchi accepts. He has an open panel in New Haven, CT according to Yale New Haven Health.